France versus Germany: differences and similarities in determining the added therapeutic value of medicines

Pauline Kilwing, Charalabos-Markos Dintsios

Open source

DOI
10.1007/s10198-026-01911-w
Published
2026-04-15
Container
The European Journal of Health Economics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10198-026-01911-w,
  title = {France versus Germany: differences and similarities in determining the added therapeutic value of medicines},
  author = {Pauline Kilwing and Charalabos-Markos Dintsios},
  year = {2026},
  journal = {The European Journal of Health Economics},
  doi = {10.1007/s10198-026-01911-w},
  url = {https://doi.org/10.1007/s10198-026-01911-w}
}

RIS

TY  - JOUR
TI  - France versus Germany: differences and similarities in determining the added therapeutic value of medicines
AU  - Pauline Kilwing
AU  - Charalabos-Markos Dintsios
PY  - 2026
JO  - The European Journal of Health Economics
DO  - 10.1007/s10198-026-01911-w
UR  - https://doi.org/10.1007/s10198-026-01911-w
ER  - 

APA

Kilwing, P., & Dintsios, C. (2026). France versus Germany: differences and similarities in determining the added therapeutic value of medicines. The European Journal of Health Economics. https://doi.org/10.1007/s10198-026-01911-w

Source records